Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-011162-29Phase 2Active
Phase 2, open-label, single-arm trial of docetaxel, cisplatin, fluorouracil, carboplatin, methotrexate and 1 more in peritoneal carcinomatosis (PC), sponsored by Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón. Primary endpoints: Disease-free survival and Overall survival. Started Mar 2009; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-011162-29.